Clinical trials cost billions, yet promising drugs still fail for preventable reasons. Discover how the wrong laboratory partner can quietly derail a study—and why choosing the right one matters.
When Good Drugs Die in Bad Trials Read More »
How MLM’s Global Gating Strategy Elevates Your Research Unlocking Consistency in Global Clinical Trials: The Role of Flow Cytometry and Global Gating In the complex journey of drug discovery and development, consistency is key. At MLM Medical Labs, flow cytometry is a cornerstone technique in the drug development process, delivering deep insights into immune responses,
How MLM’s Global Gating Strategy Elevates Your Research Read More »
Key Flow Cytometry Markers Assessed Across Multiple Disease Categories Flow cytometry is an invaluable tool for multidimensional cellular analysis and continues to expand its applications in clinical research. At MLM Medical Labs, each assay is tailored to the therapeutic area, leveraging advanced markers and techniques. Below are key markers that can be assessed across multiple
Key Flow Cytometry Markers Assessed Across Multiple Disease Categories Read More »
MLM Medical Labs leads in IVDR LDT Alzheimer’s biomarker testing with a validated Lumipulse® pTau217/Beta-Amyloid 1-42 plasma assay, enabling reliable, regulatory-compliant data to support global Alzheimer’s clinical trials.
Sponsors of global clinical trials don’t need another oversized, bureaucratic lab — they need a right-sized, science-first partner. Discover how MLM Medical Labs delivers proactive support, direct scientific access, and operational excellence across every phase of complex clinical trials worldwide.
What Global Trial Sponsors Need Now: A Proven, Right-Sized Central Lab Partner Read More »
Infectious disease trials demand speed, precision, and regional expertise. This article explores the top operational challenges sponsors face in Sub-Saharan Africa—and how MLM Medical Labs and Cytespace Africa Laboratories deliver a purpose-built, lab-integrated solution to accelerate timelines and improve data integrity.
A mid-sized biopharmaceutical company planning a global Phase II immuno-oncology trial in advanced solid tumors would face a critical operational challenge: ensuring consistent, high-quality PBMC processing across diverse geographies. PBMC-based immune monitoring is central to their biomarker strategy, but coordinating this across five continents introduces scientific and logistical risks.
This Applied Insights Brief outlines the likely challenges such a sponsor would encounter, how MLM Medical Labs would structure a tailored solution, and the measurable outcomes sponsors could expect by partnering with MLM.
CD4/CD8 Duplex Immunofluorescence : High-Resolution Immune Profiling from a Single Slide Read More »
A mid-sized biopharmaceutical company planning a global Phase II immuno-oncology trial in advanced solid tumors would face a critical operational challenge: ensuring consistent, high-quality PBMC processing across diverse geographies. PBMC-based immune monitoring is central to their biomarker strategy, but coordinating this across five continents introduces scientific and logistical risks.
This Applied Insights Brief outlines the likely challenges such a sponsor would encounter, how MLM Medical Labs would structure a tailored solution, and the measurable outcomes sponsors could expect by partnering with MLM.
Targeting the IRE1α-XBP1 Axis: A Novel Approach in ALI Treatment Read More »
A mid-sized biopharmaceutical company planning a global Phase II immuno-oncology trial in advanced solid tumors would face a critical operational challenge: ensuring consistent, high-quality PBMC processing across diverse geographies. PBMC-based immune monitoring is central to their biomarker strategy, but coordinating this across five continents introduces scientific and logistical risks.
This Applied Insights Brief outlines the likely challenges such a sponsor would encounter, how MLM Medical Labs would structure a tailored solution, and the measurable outcomes sponsors could expect by partnering with MLM.
Managing PBMC Complexity in Global Immuno-Oncology Trials Read More »
Love Your Research, Love Healthy Bodies: Advancing Obesity and Metabolic Health Research by Katie Dineen, B.S., Business Development Manager Preclinical Laboratory Services Valentine’s Day is a time to celebrate love, care, and well-being—not just for each other, but also for the health of our bodies. At MLM Medical Labs, we are dedicated to supporting research
Love Your Research, Love Healthy Bodies: Advancing Obesity and Metabolic Health Research Read More »
